Camilla Stapnes

The proteasome inhibitors bortezomib and PR‐171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells

Camilla Stapnes, Anne P. Døskeland, Kimberley Joanne Hatfield et al. · British Journal of Haematology · 2007 · 118 citations · Full text

Medicine, Hematology, Pharmacology +15

A Novel, Extraneuronal Role for Cyclin-dependent Protein Kinase 5 (CDK5)

Tone Sandal, Camilla Stapnes, Hans Kleivdal et al. · Journal of Biological Chemistry · 2002 · 57 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid

Anita Ryningen, Camilla Stapnes, Philippe Lassalle et al. · Leukemia Research · 2008 · 54 citations

Medicine, Hematology, Pharmacology +10

<i>In vivo</i>biological effects of ATRA in the treatment of AML

Anita Ryningen, Camilla Stapnes, Kristin Paulsen et al. · Expert Opinion on Investigational Drugs · 2008 · 36 citations

Medicine, Pharmacology, Pharmacotherapy +13

Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in susceptibility to histone deacetylase inhibitors

Camilla Stapnes, Anita Ryningen, Kimberley Joanne Hatfield et al. · International Journal of Oncology · 2007 · 31 citations · Full text

Medicine, Oncology, Pharmacology +12